Literature DB >> 15290270

Chronic mucocutaneous candidiasis and primary hypothyroidism in two families.

Anne Grethe Myhre1, Asbjørg Stray-Pedersen, Steinar Spangen, Eigill Eide, Dag Veimo, Per Morten Knappskog, Tore G Abrahamsen, Eystein S Husebye.   

Abstract

UNLABELLED: We describe the clinical and immunological features of two families with chronic mucocutaneous candidiasis (CMC) and primary hypothyroidism. Family A includes three siblings with both candidiasis and hypothyroidism and four individuals with hypothyroidism only. Family B includes four members with candidiasis, of whom one (a male child) also had hypothyroidism. All individuals affected with CMC had suffered from oral candidiasis and onychomycosis since infancy. Facial seborrhoic dermatitis, general folliculitis and scaling blepharitis were main manifestations. Hypothyroidism became evident during childhood. No thyroid antibodies were present in the affected siblings in family A, while the male in family B with hypothyroidism had antibodies against thyroid peroxidase at diagnosis. Immunological evaluation revealed intra-individual variations in serum immunoglobulin levels, lymphocyte subsets and proliferative responses, but there were no consistent abnormalities. Vaccine responses were normal. AIRE gene region microsatellite markers did not segregate with disease nor were autoantibodies typical for autoimmune polyendocrine syndrome type 1 detected in the families.
CONCLUSION: The link between hypothyroidism and chronic mucocutaneous candidiasis remains to be identified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15290270     DOI: 10.1007/s00431-004-1516-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  30 in total

1.  Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors.

Authors:  I S Aaberge; T E Steinsvik; E C Groeng; R B Leikvold; M Løvik
Journal:  Clin Exp Immunol       Date:  1996-07       Impact factor: 4.330

2.  Hypothyroidism after treatment with ketoconazole.

Authors:  N H Kitching
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-18

3.  The cellular immune defect in chronic mucocutaneous candidiasis.

Authors:  R A Chilgren; H J Meuwissen; P G Quie; R A Good; R Hong
Journal:  Lancet       Date:  1969-06-28       Impact factor: 79.321

4.  Immunological observations in chronic mucocutaneous candidiasis.

Authors:  L Canales; R O Middlemas; J M Louro; M A South
Journal:  Lancet       Date:  1969-09-13       Impact factor: 79.321

Review 5.  Allergic rhinitis update: Epidemiology and natural history.

Authors:  J A Bellanti; D B Wallerstedt
Journal:  Allergy Asthma Proc       Date:  2000 Nov-Dec       Impact factor: 2.587

Review 6.  Chronic mucocutaneous candidiasis.

Authors:  C H Kirkpatrick
Journal:  Pediatr Infect Dis J       Date:  2001-02       Impact factor: 2.129

7.  Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.

Authors:  T Nordøy; A Husebekk; I S Aaberge; P A Jenum; H H Samdal; L B Flugsrud; A C Kristoffersen; H Holte; S Kvaløy; A Kolstad
Journal:  Bone Marrow Transplant       Date:  2001-10       Impact factor: 5.483

8.  Chronic mucocutaneous candidiasis. Immunologic studies of three generations of a single family.

Authors:  W M Sams; J L Jorizzo; R Snyderman; B V Jegasothy; F E Ward; M Weiner; J G Wilson; W J Yount; S B Dillard
Journal:  Am J Med       Date:  1979-12       Impact factor: 4.965

9.  Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

Authors:  P Ahonen; S Myllärniemi; I Sipilä; J Perheentupa
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

10.  Identification of tryptophan hydroxylase as an intestinal autoantigen.

Authors:  O Ekwall; H Hedstrand; L Grimelius; J Haavik; J Perheentupa; J Gustafsson; E Husebye; O Kämpe; F Rorsman
Journal:  Lancet       Date:  1998-07-25       Impact factor: 79.321

View more
  4 in total

Review 1.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

Review 2.  Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.

Authors:  Anne Puel; Sophie Cypowyj; László Maródi; Laurent Abel; Capucine Picard; Jean-Laurent Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-12

3.  Chronic mucocutaneous candidiasis with endocrinopathy - case report.

Authors:  Aleksandra Lesiak; Anna Erkiert-Polguj; Bożena Dziankowska-Bartkowiak; Anna Sysa-Jędrzejowska; Joanna Narbutt
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

4.  The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1.

Authors:  Mark Depner; Sebastian Fuchs; Jan Raabe; Natalie Frede; Cristina Glocker; Rainer Doffinger; Effrossyni Gkrania-Klotsas; Dinakantha Kumararatne; T Prescott Atkinson; Harry W Schroeder; Tim Niehues; Gregor Dückers; Asbjørg Stray-Pedersen; Ulrich Baumann; Reinhold Schmidt; Jose L Franco; Julio Orrego; Moshe Ben-Shoshan; Christine McCusker; Cristina Miuki Abe Jacob; Magda Carneiro-Sampaio; Lisa A Devlin; J David M Edgar; Paul Henderson; Richard K Russell; Anne-Bine Skytte; Suranjith L Seneviratne; Jennifer Wanders; Hans Stauss; Isabelle Meyts; Leen Moens; Milos Jesenak; Robin Kobbe; Stephan Borte; Michael Borte; Dowain A Wright; David Hagin; Troy R Torgerson; Bodo Grimbacher
Journal:  J Clin Immunol       Date:  2015-11-25       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.